Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022
Sign Up to like & getrecommendations! Published in 2023 at "Expert Opinion on Drug Discovery"
DOI: 10.1080/17460441.2023.2174097
Abstract: ABSTRACT Introduction Glioblastoma (GBM) is the most common primary brain tumor in adults. GBM treatment options have been the same for the past 30 years and have only modestly extended survival, despite aggressive multimodal treatments.… read more here.
Keywords: glioblastoma; glioblastoma treatment; slowly moves; treatment slowly ... See more keywords